Search

Salverda, Merijn LM, Arjan GM De Visser, and Miriam Barlow. 2010. “Natural Evolution of TEM-1 β-Lactamase: Experimental Reconstruction and Clinical Relevance”. FEMS Microbiology Reviews 34 (6): 1015-36.

Barlow, Miriam, Javad Fatollahi, and Merijn Salverda. 2008. “Evidence for Recombination Among the Alleles Encoding TEM and SHV $\beta$-Lactamases”. Journal of Antimicrobial Chemotherapy 63 (2): 256–259.

Mroczkowska, Joanna E, and Miriam Barlow. 2008. “Fitness Trade-Offs in BlaTEM Evolution”. Antimicrobial Agents and Chemotherapy 52 (7): 2340–2345.

Hujer, Kristine M, Nashaat S Hamza, Andrea M Hujer, Federico Perez, Marion S Helfand, Christopher R Bethel, Jodi M Thomson, Vernon E Anderson, Miriam Barlow, and Louis B Rice. 2005. “Identification of a New Allelic Variant of the Acinetobacter Baumannii Cephalosporinase, ADC-7 β-Lactamase: Defining a Unique Family of Class C Enzymes”. Antimicrobial Agents and Chemotherapy 49 (7): 2941-48.

Hall, Barry G, and Miriam Barlow. 2004. “Evolution of the Serine β-Lactamases: Past, Present and Future”. Drug Resistance Updates 7 (2): 111-23.

Francino, Pilar. 2012. “The Ecology of Bacterial Genes and the Survival of the New”. International Journal of Evolutionary Biology 2012.

Seronello, Scott, Jessica Montanez, Kristen Presleigh, Miriam Barlow, Seung Bum Park, and Jinah Choi. 2011. “Ethanol and Reactive Species Increase Basal Sequence Heterogeneity of Hepatitis C Virus and Produce Variants With Reduced Susceptibility to Antivirals”. PLoS One 6 (11): e27436.

Acar, Jacques, Julian Davies, and Merry Buckley. 2009. “Antibiotic Resistance: An Ecological Perspective on an Old Problem.”

Baquirin, Mia HC, and Miriam Barlow. 2008. “Evolution and Recombination of the Plasmidic Qnr Alleles”. Journal of Molecular Evolution 67 (1): 103–110.

Welsh, Kerry J, Miriam Barlow, Fred C Tenover, James W Biddle, Kamile Rasheed, Leigh Ann Clark, and John E McGowan. 2005. “Experimental Prediction of the Evolution of Ceftazidime Resistance in the CTX-M-2 Extended-Spectrum Beta-Lactamase”. Antimicrobial Agents and Chemotherapy 49 (3): 1242-44.